Alshoubaki, Yasmin K. http://orcid.org/0000-0001-6031-531X
Lu, Yen-Zhen http://orcid.org/0000-0003-4262-3436
Legrand, Julien M. D. http://orcid.org/0000-0001-5577-5645
Karami, Rezvan
Fossat, Mathilde
Salimova, Ekaterina
Julier, Ziad
Martino, Mikaƫl M. http://orcid.org/0000-0002-5012-4605
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1140229, APP1176213)
Sylvia and Charles Viertel Charitable Foundation
Article History
Received: 18 November 2022
Accepted: 4 May 2023
First Online: 22 May 2023
Competing interests
: Monash University has filed for patent protection on the molecular design described herein, and Z.J. and M.M.M. are named as inventors. Z.J. and M.M.M are co-founders of Orio Therapeutics, which entered a license agreement with Monash University to secure the exclusive rights to commercialise the technology. The other authors declare that they have no competing interests.